Wednesday, July 8, 2026

pharma · Alzheimer's Disease · Type 2 Diabetes Mellitus · VTVT

vTv Therapeutics

vTv Therapeutics clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

3980 Premier Dr, Suite 110, High Point, North Carolina 27265, US HQ
55 Employees
Public company Type
VTVT · NYSE Ticker
Company details
Status
Public
HQ
3980 Premier Dr, Suite 110, High Point, North Carolina 27265, US
Employees
55
Programs
14
Drugs
2
Patents
50
Intelligence · Clinical Programs

vTv Therapeutics projects

2 ClinicalTrials.gov programs sponsored by vTv Therapeutics.

vTv Therapeutics has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. TTP4000

    vTv Therapeutics

    Alzheimer's Disease

    phase 1 small molecule completed

    1 trial
  2. TTP607

    vTv Therapeutics

    Advanced Cancers

    phase 1 small molecule terminated

    1 trial

Frequently asked questions

How many clinical projects does vTv Therapeutics have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.